| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5575118 | PM&R | 2016 | 10 Pages |
Abstract
Zoledronic acid is effective at mitigating bone loss after SCI. Duration of efficacy and activity at different skeletal sites may differ from that observed in able-bodied individuals and needs further study.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Thomas J. MD, PhD, Ki MD, Julia BS, Renita BS, Narina BS, David MD,